An estimated 24% of women in the United States will suffer from a pelvic floor disorder in her lifetime, with that varying significantly with age, as by the time women are 80 years old, up to 50% are affected. This number is expected to increase by over 70% by the year 2050, primarily due to an aging population.1 This makes them one of the most common health issues for women, and yet they are vastly underdiagnosed and undertreated.

September 15, 2022 – Intelerad Medical Systems, a leading global provider of enterprise imaging solutions, announced its acquisition of Life Image, one of the largest image exchange networks of curated clinical and imaging data.

Large-scale mergers and acquisitions are causing increased strain on IT teams responsible for consolidating and managing infrastructure across an organization. When coupled with AI integrations, cloud migration, and other technological advancements, the already immense pressure on IT infrastructure is being exacerbated to new levels.

September 14, 2022 — A revolutionary mobile imaging system that delivered the industry’s first collapsible column is celebrating its 10-year anniversary. The popular DRX-Revolution Mobile X-ray System paved the way for market-leading innovation from Carestream that continues to improve the lives of customers today.  

September 14, 2022 — An AI tool is highly effective at detecting pancreatic cancer on CT, accor

September 14, 2022 — When double reading screening mammograms, radiographers (technologists) trained for the task perform as well as radiologists in key areas, according to a study published in 

Due to the siloed nature of healthcare networks today, approximately 40% of all medical imaging that patients receive is repeated, leading to higher healthcare costs and undue radiation exposure

“Zero-COVID” policies have had a massive impact around the world. One consequence has been the recent global shortage in iohexol iodinated contrast media (ICM) due to the temporary closure of one manufacturing facility in Shanghai.
As the world, particularly the imaging community, is aware, disruptions in a pharmaceutical supply chain have impacted the global availability, and shortage of, iohexol iodinated contrast media (ICM), a common agent used in a multitude of CT and X-ray exams.

The theme “Everyday progress” seems appropriate for the imaging community in 2022. What a year it’s been. Supply disruptions which began when COVID-19 appeared on the world scene have severely impacted the way imaging is being managed, how exams are conducted, and how the industry looks to future modifications to work with the harsh realities that emerge from supply and demand issues looming large.

According to statistics from breastcancer.org, about 1 in 8 women in the US (around 13%) will develop invasive breast cancer over the course of her lifetime. In 2022 alone, an estimated 287,850 new cases of invasive breast cancer are expected to be diagnosed in women in the US, along with 51,400 new cases of non-invasive (in situ) breast cancer. About 43,250 of these women are expected to die from breast cancer.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now